View original post here:
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
Go here to read the rest:
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
Here is the original post:
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
Continue reading here:
Opthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement Offer
Here is the original post:
AstraZeneca Closes Acquisition of Amolyt Pharma